2025 年臨床前影像全球市場報告

預計未來幾年臨床前成像市場規模將強勁成長。到 2029 年，這一數字將成長至 48.3 億美元，複合年成長率為 6.9%。預測期內的成長歸因於個人化醫療的採用、分子影像的進步、藥物開發的外包、監管支持以及慢性病數量的增加。預測期內的關鍵趨勢包括綠色成像技術、技術進步、活性化的研發活動、合作與夥伴關係以及即時成像。

預計慢性病的激增將成為臨床前影像市場成長的主要動力。慢性病的特徵是健康狀況長期持續三個月以上，需要持續的醫療管理，並嚴重影響個人的生活品質。臨床前影像工具透過可視化骨骼結構和肺功能在識別這些疾病方面發揮關鍵作用。它還將有助於慢性病研究，透過可視化疾病進展提供更好的整體理解。例如，根據世界衛生組織（WHO）2022年9月在《2022年要聞》中發布的資料，全球74%的死亡是由於非傳染性疾病（NCD）或慢性病造成的，每年導致4,100萬人死亡。其中包括1,790萬人死於心血管疾病，930萬人死於癌症，410萬人死於慢性呼吸道疾病，200萬人死於糖尿病。因此，慢性病的增加正在推動臨床前影像市場的成長。

藥品需求的不斷成長正在推動臨床前成像市場的擴張。藥物包括用於預防、診斷或治療疾病的處方物質，製藥業從臨床前影像中受益匪淺。這種成像技術可在進入臨床試驗之前提供有關藥物功效、安全性和作用機制的寶貴見解，從而提高決策能力。例如，歐盟統計局在2023年4月報告稱，2022年藥品和醫藥產品出口達3,070億美元（2,870億歐元），與前一年同期比較成長22%。同時，藥品進口額從 2021 年的 1,070 億美元（1,000 億歐元）增加到 2022 年的 1,200 億美元（1,120 億歐元）。此外，德國製藥公司默克集團在 2023 年 2 月報告稱，其 2022 年的藥品銷售額將達到 593 億美元，比 2021 年全年成長 22%。因此，對藥品的需求不斷成長是臨床前成像市場成長的主要驅動力。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球臨床前影像 PESTEL 分析（政治、社會、技術、環境、法律、促進因素、限制因素）
• 最終用途產業分析
• 全球臨床前影像市場：成長率分析
• 全球臨床前影像市場表現：規模與成長，2019 年至 2024 年
• 全球臨床前影像市場預測：規模與成長，2024-2029 年，2034 年
• 全球臨床前影像總目標市場 (TAM)

第6章 市場細分

• 全球臨床前影像市場（依模式分類）：2019-2024 年、2024-2029 年、2034 年業績及預測
• 光學成像系統
• 臨床前核子造影系統
• 微型磁振造影系統
• 微型超音波系統
• 微電腦斷層掃描系統
• 臨床前光聲成像系統
• 臨床前磁粒子成像 (MPI) 系統
• 全球臨床前影像市場（按試劑、效能和預測）2019-2024 年、2024-2029 年、2034 年
• 臨床前光學成像試劑
• 臨床前核子造影試劑
• 臨床前 MRI顯影劑
• 臨床前超音波顯影劑
• 臨床前 CT顯影劑
• 全球臨床前影像市場（按最終用戶、業績和預測）2019-2024、2024-2029F、2034F
• 醫院
• 診斷中心
• 其他最終用戶
• 全球臨床前影像市場、光學影像系統細分（按模式、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 生物發光成像
• 螢光影像
• 全球臨床前影像市場、臨床前核子影像系統細分（按模式、效能和預測），2019-2024 年、2024-2029 年、2034 年
• 正子斷層掃描 (PET)
• 單光子發射電腦斷層掃描 (SPECT)
• 全球臨床前影像市場、微磁振造影(Micro-MRI) 系統細分（按模式、效能和預測），2019-2024 年、2024-2029 年、2034 年
• 高解析度微型磁振造影系統
• 功能性微型磁振造影系統
• 全球臨床前影像市場、微型超音波系統細分（按模式、效能和預測），2019-2024 年、2024-2029 年、2034 年
• 高頻超音波影像
• 即時微超音波系統
• 全球臨床前影像市場、微電腦斷層掃描 (Micro-CT) 系統細分（按模式、效能和預測），2019-2024 年、2024-2029 年、2034 年
• 活體微型CT系統
• 體外微型CT系統
• 全球臨床前影像市場、臨床前光聲影像系統細分（按模式、效能和預測），2019-2024 年、2024-2029 年、2034 年
• 多波長光聲成像
• 混合光聲成像系統
• 全球臨床前影像市場、臨床前磁粒子成像 (MPI) 系統細分（按模式、性能和預測），2019-2024 年、2024-2029 年、2034 年
• MPI 用於細胞追蹤
• MPI 用於血管成像

第7章 區域和國家分析

• 全球臨床前影像市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 全球臨床前影像市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 臨床前影像市場：競爭格局
• 臨床前影像市場：公司簡介
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • FUJIFILM Visualsonics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Konica Minolta Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Miltenyi Biotech
• Sofie Biosciences Inc.
• Promega Corporation
• Ion Beam Applications SA
• Nihon Kohden
• Piramal Enterprises Ltd
• LI-COR Biosciences Inc.
• Aspect Imaging Ltd
• Capintec Inc.
• Spectral Instruments Inc.
• Mediso Ltd
• MR Solutions Ltd
• Biospace Lab SA

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年臨床前影像市場：提供新機會的國家
• 2029 年臨床前影像市場：提供新機會的細分市場
• 2029 年臨床前影像市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

Preclinical imaging encompasses the utilization of various techniques to observe and analyze biological processes within animal models, preceding their application in human clinical trials. These imaging methods enable researchers to monitor disease progression, assess the effectiveness and safety of potential treatments, and acquire deeper insights into the underlying biological mechanisms of diseases.

Key modalities employed in preclinical imaging include optical imaging systems, preclinical nuclear imaging systems, micro-magnetic resonance imaging systems, micro-ultrasound systems, micro-computed tomography systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems. Optical imaging systems involve technologies that leverage light to visualize and capture images of biological tissues, cells, or molecules. They are utilized during the preclinical stage for research purposes, disease diagnosis, monitoring tumor blood vessel growth, and tracking tissue blood oxygenation in animals. This encompasses a spectrum of reagents such as preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents. Hospitals, diagnostic centers, and other entities form the primary user base for these technologies.

The preclinical imaging market research report is one of a series of new reports from The Business Research Company that provides preclinical imaging market statistics, including preclinical imaging industry global market size, regional shares, competitors with a preclinical imaging market share, detailed preclinical imaging market segments, market trends and opportunities, and any further data you may need to thrive in the preclinical imaging industry. This preclinical imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The preclinical imaging market size has grown strongly in recent years. It will grow from $3.46 billion in 2024 to $3.69 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to government initiatives, the growing prevalence of diseases, expanding applications, increasing awareness, and emerging markets expansion

The preclinical imaging market size is expected to see strong growth in the next few years. It will grow to $4.83 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to personalized medicine adoption, advancements in molecular imaging, drug development outsourcing, regulatory support, and rising chronic diseases. Major trends in the forecast period include green imaging technologies, technological advancements, a rise in R&D activities, collaborations and partnerships, and real-time imaging.

The anticipated surge in chronic diseases is poised to be a significant driver of growth in the preclinical imaging market. Chronic diseases, characterized by prolonged health conditions lasting three months or more, necessitate ongoing medical management and can substantially impact individuals' quality of life. Preclinical imaging tools play a crucial role in identifying these diseases by visualizing bone structure and lung function. Moreover, they contribute to studying chronic diseases, enabling the visualization of disease progression and enhancing overall understanding. For instance, data from the World Health Organization (WHO) 2022 Highlights in September 2022 revealed that 74% of global deaths are caused by Noncommunicable diseases (NCDs) or chronic diseases, amounting to 41 million deaths annually. Notably, this includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increasing prevalence of chronic diseases is a driving force behind the growth of the preclinical imaging market.

The growing demand for pharmaceutical products is set to propel the expansion of the preclinical imaging market. Pharmaceutical products, encompassing substances formulated to prevent, diagnose, or treat medical conditions, benefit significantly from preclinical imaging in the pharmaceutical industry. This imaging technology enhances decision-making by providing valuable insights into drug efficacy, safety, and mechanisms of action before progressing to clinical trials. For instance, Eurostat reported in April 2023 that exports of medicinal and pharmaceutical products increased to $307 billion (€287 billion) in 2022, reflecting a 22% rise from the previous year. Concurrently, pharmaceutical product imports increased from $107 billion (€100 billion) in 2021 to $120 billion (€112 billion) in 2022. Furthermore, the Merck Group, a Germany-based pharmaceutical company, reported in February 2023 that pharmaceutical product sales for the year 2022 reached $59.3 billion, marking a 22% increase over the full year 2021. Consequently, the heightened demand for pharmaceutical products emerges as a key driver for the growth of the preclinical imaging market.

Product innovation stands out as a prominent trend gaining traction in the preclinical imaging market, with major companies actively engaged in developing cutting-edge products to maintain their market positions. A notable example is Fujifilm VisualSonics Inc., a Canada-based biomedical company specializing in imaging systems, which introduced Vevo F2 for preclinical imaging in May 2022. Distinguished as the first preclinical ultra-high- to low-frequency (71 MHz-1 MHz) ultrasonic and photoacoustic imaging system, Vevo F2 incorporates HD image processing technology and a novel signal pathway. These features contribute to enhanced image clarity, improved frame rates, and customization options tailored to precision imaging demands. With a broad scope of anatomical targets and high-resolution imaging capabilities, Vevo F2 is well-suited for diverse research applications.

Major players in the preclinical imaging market are intensifying their focus on introducing next-generation imaging systems, positioning themselves strategically to gain a competitive advantage. Next-generation imaging systems represent advanced technologies that surpass current capabilities, integrating cutting-edge features. In a significant development, Revvity Inc., a US-based biotechnology company, launched next-generation imaging systems in September 2023, aimed at driving innovation in various preclinical research applications. The product lineup includes the next-generation IVIS Spectrum 2 and IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system seamlessly integrating 2D optical and full 3D imaging. These imaging systems boast enhanced image-based capabilities and are designed to streamline the imaging workflow, marking a significant stride in advancing preclinical imaging technologies.

In February 2024, Bruker Corporation, a US-based medical devices company, acquired Spectral Instruments Imaging (SII) for $37.5 million. This acquisition demonstrates Bruker's commitment to advancing scientific research and enhancing its technological capabilities in the life sciences sector. Spectral Instruments Imaging (SII) is a US-based manufacturer of preclinical optical systems for bioluminescent, fluorescent, and X-ray imaging.

Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the preclinical imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The preclinical imaging market includes of revenues earned by entities by providing preclinical imaging services such as magnetic resonance imaging, positron emission tomography, computed tomography, and optical imaging services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Preclinical Imaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on preclinical imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for preclinical imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The preclinical imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Modality: Optical Imaging Systems; Preclinical Nuclear Imaging Systems; Micro-Magnetic Resonance Imaging Systems; Micro-Ultrasound Systems; Micro-Computed Tomography Systems; Preclinical Photoacoustic Imaging Systems; Preclinical Magnetic Particle Imaging (MPI) Systems
• 2) By Reagents: Preclinical Optical Imaging Reagents; Preclinical Nuclear Imaging Reagents; Preclinical MRI Contrast Agents; Preclinical Ultrasound Contrast Agents; Preclinical CT Contrast Agents
• 3) By End User: Hospital; Diagnostics Center; Other End-User
• Subsegments:
• 1) By Optical Imaging Systems: Bioluminescence Imaging; Fluorescence Imaging
• 2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET); Single-Photon Emission Computed Tomography (SPECT)
• 3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems; Functional Micro-MRI Systems
• 4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging; Real-Time Micro-Ultrasound Systems
• 5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems; Ex Vivo Micro-CT Systems
• 6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging; Hybrid Photoacoustic Imaging Systems
• 7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking; MPI For Vascular Imaging
• Companies Mentioned: Thermo Fisher Scientific Inc.; FUJIFILM Visualsonics Inc.; Konica Minolta Inc.; Agilent Technologies Inc.; PerkinElmer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Preclinical Imaging Market Characteristics

3. Preclinical Imaging Market Trends And Strategies

4. Preclinical Imaging Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Preclinical Imaging Growth Analysis And Strategic Analysis Framework

• 5.1. Global Preclinical Imaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Preclinical Imaging Market Growth Rate Analysis
• 5.4. Global Preclinical Imaging Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Preclinical Imaging Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Preclinical Imaging Total Addressable Market (TAM)

6. Preclinical Imaging Market Segmentation

• 6.1. Global Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Optical Imaging Systems
• Preclinical Nuclear Imaging Systems
• Micro-magnetic Resonance Imaging Systems
• Micro-Ultrasound Systems
• Micro-computed Tomography Systems
• Preclinical Photoacoustic Imaging Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems
• 6.2. Global Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical Optical Imaging Reagents
• Preclinical Nuclear Imaging Reagents
• Preclinical MRI Contrast Agents
• Preclinical Ultrasound Contrast Agents
• Preclinical CT Contrast Agents
• 6.3. Global Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Diagnostics Center
• Other End-User
• 6.4. Global Preclinical Imaging Market, Sub-Segmentation Of Optical Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioluminescence Imaging
• Fluorescence Imaging
• 6.5. Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Nuclear Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Positron Emission Tomography (PET)
• Single-Photon Emission Computed Tomography (SPECT)
• 6.6. Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Magnetic Resonance Imaging (Micro-MRI) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Resolution Micro-MRI Systems
• Functional Micro-MRI Systems
• 6.7. Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Ultrasound Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High-Frequency Ultrasound Imaging
• Real-Time Micro-Ultrasound Systems
• 6.8. Global Preclinical Imaging Market, Sub-Segmentation Of Micro-Computed Tomography (Micro-CT) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In Vivo Micro-CT Systems
• Ex Vivo Micro-CT Systems
• 6.9. Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Photoacoustic Imaging Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multi-Wavelength Photoacoustic Imaging
• Hybrid Photoacoustic Imaging Systems
• 6.10. Global Preclinical Imaging Market, Sub-Segmentation Of Preclinical Magnetic Particle Imaging (MPI) Systems, By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• MPI For Cell Tracking
• MPI For Vascular Imaging

7. Preclinical Imaging Market Regional And Country Analysis

• 7.1. Global Preclinical Imaging Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Preclinical Imaging Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Preclinical Imaging Market

• 8.1. Asia-Pacific Preclinical Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Preclinical Imaging Market

• 9.1. China Preclinical Imaging Market Overview
• 9.2. China Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Preclinical Imaging Market

• 10.1. India Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Preclinical Imaging Market

• 11.1. Japan Preclinical Imaging Market Overview
• 11.2. Japan Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Preclinical Imaging Market

• 12.1. Australia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Preclinical Imaging Market

• 13.1. Indonesia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Preclinical Imaging Market

• 14.1. South Korea Preclinical Imaging Market Overview
• 14.2. South Korea Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Preclinical Imaging Market

• 15.1. Western Europe Preclinical Imaging Market Overview
• 15.2. Western Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Preclinical Imaging Market

• 16.1. UK Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Preclinical Imaging Market

• 17.1. Germany Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Preclinical Imaging Market

• 18.1. France Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Preclinical Imaging Market

• 19.1. Italy Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Preclinical Imaging Market

• 20.1. Spain Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Preclinical Imaging Market

• 21.1. Eastern Europe Preclinical Imaging Market Overview
• 21.2. Eastern Europe Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Preclinical Imaging Market

• 22.1. Russia Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Preclinical Imaging Market

• 23.1. North America Preclinical Imaging Market Overview
• 23.2. North America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Preclinical Imaging Market

• 24.1. USA Preclinical Imaging Market Overview
• 24.2. USA Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Preclinical Imaging Market

• 25.1. Canada Preclinical Imaging Market Overview
• 25.2. Canada Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Preclinical Imaging Market

• 26.1. South America Preclinical Imaging Market Overview
• 26.2. South America Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Preclinical Imaging Market

• 27.1. Brazil Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Preclinical Imaging Market

• 28.1. Middle East Preclinical Imaging Market Overview
• 28.2. Middle East Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Preclinical Imaging Market

• 29.1. Africa Preclinical Imaging Market Overview
• 29.2. Africa Preclinical Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Preclinical Imaging Market, Segmentation By Reagents, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Preclinical Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Preclinical Imaging Market Competitive Landscape And Company Profiles

• 30.1. Preclinical Imaging Market Competitive Landscape
• 30.2. Preclinical Imaging Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. FUJIFILM Visualsonics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Konica Minolta Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Preclinical Imaging Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. Bruker Corporation
• 31.3. Miltenyi Biotech
• 31.4. Sofie Biosciences Inc.
• 31.5. Promega Corporation
• 31.6. Ion Beam Applications S.A
• 31.7. Nihon Kohden
• 31.8. Piramal Enterprises Ltd
• 31.9. LI-COR Biosciences Inc.
• 31.10. Aspect Imaging Ltd
• 31.11. Capintec Inc.
• 31.12. Spectral Instruments Inc.
• 31.13. Mediso Ltd
• 31.14. MR Solutions Ltd
• 31.15. Biospace Lab S. A.

32. Global Preclinical Imaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Preclinical Imaging Market

34. Recent Developments In The Preclinical Imaging Market

35. Preclinical Imaging Market High Potential Countries, Segments and Strategies

• 35.1 Preclinical Imaging Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Preclinical Imaging Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Preclinical Imaging Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer